Divi's Laboratories Q3 Results
- BSE: 532488
- NSE: DIVISLAB
- ISIN: INE361B01024
- Sector: Biotechnology & Drugs
BSE
6,027.00
-109.45 (-1.78%)
-109.45 (-1.78%)Volume6.05 K
Updated: Fri 6 Feb, 2026 | 15:29:45
NSE
6,024.50-117.00 (-1.91%)
-117.00 (-1.91%)Volume4.34 L
Updated: Fri 6 Feb, 2026 | 15:40:32
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
Quarter ended Dec 24
Note: Comparison is on QoQ basis
Quarterly - Divi's Laboratories Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 24 | Sep 24 | QoQ Comp | Dec 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 1,675.00 | 1,721.00 | -2.67% | 1,461.00 | 14.65% |
| Depreciation/ Amortization | 99.00 | 99.00 | 0.00% | 95.00 | 4.21% |
| Operating Income | 644.00 | 617.00 | 4.38% | 394.00 | 63.45% |
| Net Income | 589.00 | 510.00 | 15.49% | 358.00 | 64.53% |
| Other Operating Expenses Total | 357.00 | 349.00 | 2.29% | 369.00 | -3.25% |
| Net Income Before Taxes | 726.00 | 722.00 | 0.55% | 489.00 | 48.47% |
| Total Revenue | 2,319.00 | 2,338.00 | -0.81% | 1,855.00 | 25.01% |
| Selling/ General/ Admin Expenses Total | 297.00 | 304.00 | -2.30% | 268.00 | 10.82% |
| Diluted Normalized EPS | 22.20 | 19.20 | 15.63% | 13.50 | 64.44% |